SCIEX is a global leader in mass spectrometry and a trusted partner to scientists and lab analysts worldwide. The company’s innovations help protect our environment and our global food supply, advance our understanding of diseases, enable researchers to improve clinical tests, and empower pharmaceutical companies to develop more effective drugs, more quickly and at a lower cost.
The company was founded in 1970 to develop analytical instrumentation-based sensor technology for use in space. Since then, SCIEX has made its advanced analytical technology available to the worldwide scientific community. SCIEX joined the Danaher portfolio in 2009 and has gained share through its cutting-edge product development. The company’s recent partnership with the University of Manchester resulted in significant progress toward a cure for Chronic Myeloid Leukemia, a type of blood and bone marrow cancer.
SCIEX combines the power of science with unlimited imagination, bold vision and the courage to explore the mysteries of life at a molecular level to create a better world.